Corcept Therapeutics CORT has outperformed the market over the past 5 years by 26.38% on an annualized basis producing an ...

Roblox's growth narrative is strong, with rising DAUs, engagement, and revenue. Click here to read an analysis of RBLX stock now.

Truist on COST: In a new investor note, Ciccarelli said the retailer had "another strong quarter" and showed improving ...